Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

February 25, 2019

Primary Completion Date

October 29, 2019

Study Completion Date

October 29, 2019

Conditions

Knee OsteoarthritisHip Osteoarthritis

Interventions

DRUG

Low-Dose Bupivacaine

10 mg (2 mL of 0.5%) administered as an isobaric spinal anesthetic

DRUG

Mepivacaine

70 mg (3.5 mL of 2%) administered as an isobaric spinal anesthetic

Trial Locations (1)

Mayo Clinic in Rochester, Rochester